戻る Agenda
Poster Presentations and Networking Reception
Session Chair(s)
Session Chair Invited, BSN, DDS
Manager, DIA, Switzerland
Poster Presentations and Networking Reception
Speaker(s)
Michelle Hellstern, BSN
Manager, Clinical Trial Disclosure & Transparency, CSL Behring, United States
Redaction Impact and Efficiencies Assessed for Optimal Transparency Preparation for the EU Clinical Trial Regulation 536/2014
Raina Agarwal, MPHARM
Senior Manager, Kinapse Ltd, A Syneos Health Company, United States
Assessment of Anonymization Methods, Processes, and Challenges for Clinical Information Submissions to Health Canada
Cathal Gallagher
Associate Director Clinical Transparency & Trial Disclosure, Regeneron, United Kingdom
Do You Know Your Risk?
Lucy Mosquera, MSC
Senior Director, Data Science, Replica Analytics, Canada
Experiences Generating Synthetic Clinical Trial Data
Veera Thota
, MMS Holdings, United States
Automating Data Anonymization Procedures with Software
Pooja Phogat, PHD
Founder and Co-CEO, Krystelis Ltd., India
Actionable Insights for Plain Language Summary Implementation
Nirpal Virdee, MSC
Head, Transparency & Disclosure, Certara, United Kingdom
The Future of Transparency: How Global Regulatory Authorities May Expect Patient and HCP Engagement During the Drug Approval Process